2014-11-13T13:09:20-06:00 2013-12-31 420714325 MCGLADREY LLP 1861 INTERNATIONAL DRIVE SUITE 400 MCLEAN VA 22102 990 2013-01-01 521006053 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION ADVA 2027838700 701 PENNSYLVANIA AVENW NO 800 WASHINGTON DC 200042654 KENNETH MENDEZ CHIEF ADMINISTRATIVE OFFICER 2027838700 2014-11-06 1 YONG ZHANG P01249785 7033366400 2013 2015-11-30 17:44:51Z ADVAMED STEPHEN J UBL 701 PENNSYLVANIA AVENW NO 800 WASHINGTON DC 200042654 31350189 0 X WWW.ADVAMED.ORG X 1974 DE TO REPRESENT THE INTERESTS OF MANUFACTURERS OF VARIOUS MEDICAL DEVICES, DIAGNOSTIC PRODUCTS, AND MEDICAL INFORMATION SYSTEMS. 45 45 88 51 0 0 0 0 29886961 30655385 555242 480902 172846 213902 30615049 31350189 163896 167661 0 0 16413322 16518248 0 0 0 13869441 14664280 30446659 31350189 168390 0 13291335 15829980 6642805 9181450 6648530 6648530 ADVAMED ADVOCATES ON A GLOBAL BASIS FOR THE HIGHEST ETHICAL STANDARDS, TIMELY PATIENT ACCESS TO SAFE AND EFFECTIVE PRODUCTS, AND ECONOMIC POLICIES THAT REWARD VALUE CREATION. 0 0 ADVAMED'S GOVERNMENT AFFAIRS FUNCTION REPRESENTS THE INDUSTRY BEFORE STATE AND FEDERAL POLICYMAKERS, IN GOVERNOR'S OFFICES, STATE LEGISLATURES, THE UNITED STATES CONGRESS, AND RELEVANT FEDERAL AGENCIES. ADVAMED'S ADVOCACY STAFF AND OUTSIDE CONSULTANTS PROVIDE INFORMATION ON POLITICAL AND POLICY DEVELOPMENTS, AND PURSUE THE INDUSTRY'S AGENDA FOR A LEGAL, REGULATORY AND ECONOMIC ENVIRONMENT THAT ADVANCES HEALTH CARE BY ASSURING PATIENT ACCESS TO THE BENEFITS OF MEDICAL TECHNOLOGY. TAKING MEMBER COMPANY FEEDBACK FROM WORKING GROUPS AND COMMITTEES,ADVAMED STAFF PROVIDE CRITICAL INPUT TO REGULATORY AGENCIES LIKE FDAAND CMS ON REGULATIONS AND RULES THAT IMPACT THE ABILITY FOR PATIENTSTO RECEIVE TIMELY ACCESS TO LIFE CHANGING DEVICES PRODUCED BY ADVAMED MEMBERS. OUR CONSULTANTS IN JAPAN, CHINA, AND OTHER OVERSEAS MARKETS REPRESENT ADVAMED IN RAPIDLY EXPANDING OVERSEAS MARKETS AND ATTEND MEETINGS WITH GOVERNMENT OFFICIALS AND INDUSTRY COMMITTEE MEETINGS. THESE CONSULTANTS PROVIDE REAL-TIME INFORMATION AND AN INDUSTRY VOICE IN OVERSEAS MARKETS. 0 0 0 1 0 0 0 0 0 1 0 0 0 1 1 0 1 0 1 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 1 69 0 1 88 1 0 1 JA 0 0 0 0 X 45 45 1 0 0 0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 X JENNIFER BREAREY 2027838700 701 PENSYLVANIA AVE NW STE 800 WASHINGTON DC 200042654 DAVID DVORAK CHAIRMAN/DIRECTOR 1.00 X X 0 0 0 JOE ALMEIDA SECRETARY/DIRECTOR 1.00 X X 0 0 0 DAVID PEREZ TREASURER/DIRECTOR 1.00 X X 0 0 0 PETER ARDUINI DIRECTOR 1.00 X 0 0 0 MICHAEL BALL DIRECTOR 1.00 X 0 0 0 JOANNE BAUER DIRECTOR 1.00 X 0 0 0 JEFFREY BINDER DIRECTOR 1.00 X 0 0 0 BRIAN BLASER DIRECTOR 1.00 X 0 0 0 SCOTT BROOKS DIRECTOR 1.00 X 0 0 0 KEVIN BUEHLER DIRECTOR 1.00 X 0 0 0 GARY BURBACH DIRECTOR 1.00 X 0 0 0 DONALD CASEY DIRECTOR 1.00 X 0 0 0 ROBERT M DAVIS DIRECTOR 1.00 X 0 0 0 JOSEPH DEVIVO DIRECTOR 1.00 X 0 0 0 ROLAND DIGGELMANN DIRECTOR 1.00 X 0 0 0 DEBORAH DISANZO DIRECTOR 1.00 X 0 0 0 CAMILLE FARHAT DIRECTOR 1.00 X 0 0 0 MAURICE FERRE DIRECTOR 1.00 X 0 0 0 CAMERON FINDLAY DIRECTOR 1.00 X 0 0 0 VINCENT A FORLENZA DIRECTOR 1.00 X 0 0 0 MICHAEL FRAZZETTE DIRECTOR 1.00 X 0 0 0 KIERAN T GALLAHUE DIRECTOR 1.00 X 0 0 0 MICHAEL GENAU DIRECTOR 1.00 X 0 0 0 JOHN GREISCH DIRECTOR 1.00 X 0 0 0 MICHAEL GRESAVAGE DIRECTOR 1.00 X 0 0 0 TIMOTHY GUERTIN DIRECTOR 1.00 X 0 0 0 THOMAS HOOK DIRECTOR 1.00 X 0 0 0 LESTER KNIGHT DIRECTOR 1.00 X 0 0 0 KAREN LICITRA DIRECTOR 1.00 X 0 0 0 KEVIN LOBO DIRECTOR 1.00 X 0 0 0 DAVID LUCCHINO DIRECTOR 1.00 X 0 0 0 MICHAEL MAHONEY DIRECTOR 1.00 X 0 0 0 ALAN MAIN DIRECTOR 1.00 X 0 0 0 V GEORGE MALIEKEL DIRECTOR 1.00 X 0 0 0 JAMES MAZZO DIRECTOR 1.00 X 0 0 0 STEPHEN F MEYER DIRECTOR 1.00 X 0 0 0 MICHAEL R MINOGUE DIRECTOR 1.00 X 0 0 0 MICHAEL A MUSSALLEM DIRECTOR 1.00 X 0 0 0 CAROLL NEUBAUER DIRECTOR 1.00 X 0 0 0 STUART A RANDLE DIRECTOR 1.00 X 0 0 0 DEBRA RECTENWALD DIRECTOR 1.00 X 0 0 0 TIMOTHY M RING DIRECTOR 1.00 X 0 0 0 WALTER M ROSEBROUGH DIRECTOR 1.00 X 0 0 0 MICHAEL ROUSSEAU DIRECTOR 1.00 X 0 0 0 VIRGINIA RYBSKI DIRECTOR 1.00 X 0 0 0 BRENTON SAUNDERS DIRECTOR 1.00 X 0 0 0 BENSON SMITH DIRECTOR 1.00 X 0 0 0 DANIEL WECHSLER DIRECTOR 1.00 X 0 0 0 DOW WILSON DIRECTOR 1.00 X 0 0 0 JOSEPH WOODY DIRECTOR 1.00 X 0 0 0 NADIM YARED DIRECTOR 1.00 X 0 0 0 STEPHEN J UBL CHIEF EXECUTIVE OFFICER 40.00 X 1501061 0 50130 CHRISTOPHER L WHITE SR. EXEC VP, GENERAL COUNSEL 40.00 X 613814 0 43830 KENNETH MENDEZ SR EXEC VP & CAO 40.00 X 482049 0 43950 JENNIFER BRANDELY CHIEF FINANCIAL OFFICER 30.00 X 117025 0 8998 RALPH IVES EXEC VP, GLOBAL STRATEGY 40.00 X 423470 0 30879 ANN-MARIE LYNCH EXEC VP, PAYMENT & HEALTH 40.00 X 365402 0 30222 ANDREW FISH EXEC DIRECTOR, ADVAMEDDX 40.00 X 503364 0 41850 JUAN CARLOS SCOTT SR EXEC VP, GOVT AFFAIRS 40.00 X 518036 0 31035 DAVID NEXON SR. EXEC VP 40.00 X 434254 0 29739 JANET TRUNZO SR. EXEC VP, TECH & REGULATION 40.00 X 478785 0 35450 PHILIP AGRESS SR VP, GLOBAL STRATEGY 40.00 X 288582 0 30930 RICHARD PRICE SR VP, PAYMENT & HEALTH 40.00 X 320719 0 32202 STEVEN BROTMAN SR VP, PAYMENT & HEALTH 40.00 X 349281 0 43512 6395842 0 452727 42 0 1 0 STORY PARTNERS LLC 1000 POTOMAC STREET NW SUITE 102 WASHINGTON DC 20007 CONSULTING/ MONTHLY RETAINER 812396 ALBRIGHT STONEBRIDGE GROUP LLC 555 13TH ST NW STE 300 W WASHINGTON DC 20004 CONSULTING/ MONTHLY RETAINER 704236 LATHAM & WATKINS LLP 555 ELEVENTH ST NW STE 1000 WASHINGTON DC 20004 CONSULTING/ MONTHLY RETAINER 422632 ANALYSIS GROUP INC 180 N STETSON AVENUE CHICAGO IL 60601 CONSULTING/ MONTHLY RETAINER 348472 TARPLIN DOWNS & YOUNG LLC 1212 NEW YORK AVENUE NW SUITE 1050 WASHINGTON DC 20005 CONSULTING/ MONTHLY RETAINER 292500 33 MEMBERSHIP DUES 900099 28441162 28441162 SEMINARS 611430 1921760 1921760 SPECIAL PROJECTS 900099 292463 292463 30655385 480902 480902 102720 102720 OTHER INCOME 900099 102182 102182 ADMIN. FEES REVENUE 900099 9000 9000 111182 31350189 30664385 0 685804 X 167661 4822745 9238075 753611 1057420 646397 499976 60000 2377868 5245374 9605 658455 202456 1558208 1344660 1503438 555223 75354 DUES & SUBSCRIPTION 327907 TRAINING 127249 OTHER EXPENSES 118507 31350189 717 265 9493477 12003693 183977 696165 3434 569444 499107 5290443 3996549 1559924 1293894 1014194 1316783 15073 466168 5000 13291335 15829980 3948473 3978799 351357 2957902 2342975 2244749 6642805 9181450 X 6648530 6648530 6648530 6648530 13291335 15829980 0 0 X X 0 1 X 1 0 0 0 1 27462487 2377868 62664 2440532 1510437 930095 FORM 990, SCHEDULE C, PART III-B, LINE 4: THE ORGANIZATION WILL INCREASE THE LOBBYING PERCENTAGE FROM 5.5% TO 11.5% FOR THE YEAR END DECEMBER 31, 2014, TO MAKE UP FOR THE CURRENT YEAR SHORTFALL. 2419163 1633095 786068 2063619 1810784 252835 807661 552670 254991 1293894 DEFERRED ASSESSMENTS 51795 CAPITAL LEASE OBLIGATION 29862 DEFERRED RENT 480854 DEFERRED TENANT ALLOWANCE 365455 DEFERRED COMPENSATION 1316783 2244749 X 31552106 201917 201917 31350189 0 31350189 32142713 792524 792524 31350189 0 31350189 PART X, LINE 2: ADVAMED COMPLIES WITH THE ACCOUNTING STANDARD ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. MANAGEMENT EVALUATED ADVAMED'S TAX POSITIONS AND CONCLUDED THAT IT HAS TAKEN NO UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO THE CONSOLIDATED FINANCIAL STATEMENTS TO COMPLY WITH THE PROVISIONS OF THIS GUIDANCE. GENERALLY, ADVAMED IS NO LONGER SUBJECT TO U.S. FEDERAL INCOME TAX EXAMINATIONS BY TAX AUTHORITIES FOR YEARS BEFORE 2010. PART XI, LINE 2D - OTHER ADJUSTMENTS: INHEALTH REVENUE IN CONSOLIDATING FINANCIAL STATEMENTS 228. ADVAMED PAC REVENUE IN CONSOLIDATING FINANCIAL STATEMENTS 179,889. ADVAMED CA PAC REVENUE IN CONSOLIDATING FINANCIAL STATEMENTS 21,800. PART XII, LINE 2D - OTHER ADJUSTMENTS: INHEALTH EXPENSE IN CONSOLIDATING FINANCIAL STATEMENTS 614,833. ADVAMED PAC EXPENSE IN CONSOLIDATING FINANCIAL STATEMENTS 169,275. ADVAMED CA PAC EXPENSE IN CONSOLIDATING FINANCIAL STATEMENTS 8,416. EAST ASIA AND THE PACIFIC 1 4 PROGRAM SERVICES CONSULTANT IN ASIA MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 461749 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 214440 EUROPE (INCLUDING ICELAND & GREENLAND) 0 8 PROGRAM SERVICES CONSULTANT IN EUROPE MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 408187 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 42181 EUROPE (INCLUDING ICELAND & GREENLAND) 0 2 PROGRAM SERVICES MEETINGS TO PROMOTE THE HARMONIZATION OF INTERNATIONAL STANDARDS 245213 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES PREPAYMENTS FOR 2014 MEETINGS TO PROMOTE THE HARMONIZATION OF INTL STANDARDS 26363 NORTH AMERICA 0 1 PROGRAM SERVICES CONSULTANT IN NORTH AMERICA MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 40045 NORTH AMERICA 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETING 1208 SOUTH AMERICA 0 0 PROGRAM SERVICES CONSULTANT IN BRAZIL MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 346135 SOUTH AMERICA 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 13834 SOUTH AMERICA 0 0 PROGRAM SERVICES PREPAYMENTS FOR 2014 MEETINGS TO PROMOTE THE HARMONIZATION OF INTL STANDARDS 79635 SOUTH ASIA 0 1 PROGRAM SERVICES CONSULTANTS IN INDIA MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 128909 SOUTH ASIA 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 20433 1 15 0 1 1 16 1439386 588946 2028332 0 0 0 0 0 0 1 NATIONAL HEALTH COUNCIL 1730 M STREET NW STE 500 WASHINGTON DC 20036 131624107 501(C)(3) 14000 PROGRAM SUPPORT SPINA BIFIDA ASSOCIATION 4590 MACARTHUR BOULEVARD NW STE 250 250 WASHINGTON DC 20007 581342181 501(C)(3) 7500 PROGRAM SUPPORT RESEARCHAMERICA 1101 KING STREET STE 520 ALEXANDRIA VA 22314 521609875 501(C)(3) 6000 PROGRAM SUPPORT ALLIANCE FOR AGING RESEARCH 2021 K STREET NW STE 305 WASHINGTON DC 20006 541379174 501(C)(3) 10000 PROGRAM SUPPORT SOCIETY FOR WOMEN'S HEALTH RESEARCH 1828 L STREET NW STE 625 WASHINGTON DC 20036 521694732 501(C)(3) 10000 PROGRAM SUPPORT DAVID A WINSTON HEALTH POLICY FELLOWSHIP 2000 14TH STREET NORTH STE 780 ARLINGTON VA 22201 521492039 501(C)(3) 11000 PROGRAM SUPPORT AMERICAN ACTION FORUM 555 13TH STREET NW STE 510 WEST WASHINGTON DC 20004 270567765 501(C)(3) 10000 PROGRAM SUPPORT WOMENHEART 818 18TH STREET NW STE 930 WASHINGTON DC 20006 522148006 501(C)(3) 7500 PROGRAM SUPPORT 8 0 PART I, LINE 2: ADVAMED BUDGETS ANNUALLY FOR CHARITABLE DONATIONS AND OTHER CHARITABLE GIVING THAT IS CLOSELY ALIGNED WITH ITS STRATEGIC PLAN AND MISSION. IN ADDITION, ADVAMED MAY IDENTIFY CAUSES THROUGHOUT THE YEAR THAT MAY REQUIRE REPURPOSING OF FUNDS FROM ANOTHER EXPENSE CATEGORY TO SUPPORT CERTAIN MEDICAL DEVICE ISSUES OR MEMBERSHIP INITIATIVES. ALL SUCH SPENDING IS PROCESSED THROUGH ADVAMED'S PURCHASE ORDER SYSTEM, WHICH REQUIRES SEVERAL LEVELS OF EXECUTIVE APPROVAL BEFORE ANY FUNDING IS MADE. X X X 1 1 X X X X X 0 0 0 STEPHEN J UBL CHIEF EXECUTIVE OFFICER 1120470 0 351500 0 29091 0 29739 0 20391 0 1551191 0 0 0 CHRISTOPHER L WHITE SR. EXEC VP, GENERAL COUNSEL 512662 0 100000 0 1152 0 29739 0 14091 0 657644 0 0 0 KENNETH MENDEZ SR EXEC VP & CAO 398464 0 82775 0 810 0 29739 0 14211 0 525999 0 0 0 RALPH IVES EXEC VP, GLOBAL STRATEGY 367386 0 52520 0 3564 0 29739 0 1140 0 454349 0 0 0 ANN-MARIE LYNCH EXEC VP, PAYMENT & HEALTH 302902 0 62500 0 0 0 29739 0 483 0 395624 0 0 0 ANDREW FISH EXEC DIRECTOR, ADVAMEDDX 440624 0 62200 0 540 0 27639 0 14211 0 545214 0 0 0 JUAN CARLOS SCOTT SR EXEC VP, GOVT AFFAIRS 435320 0 82230 0 486 0 29739 0 1296 0 549071 0 0 0 DAVID NEXON SR. EXEC VP 360710 0 69980 0 3564 0 29739 0 0 0 463993 0 0 0 JANET TRUNZO SR. EXEC VP, TECH & REGULATION 399073 0 73540 0 6172 0 29739 0 5711 0 514235 0 0 0 PHILIP AGRESS SR VP, GLOBAL STRATEGY 250230 0 35160 0 3192 0 29660 0 1270 0 319512 0 0 0 RICHARD PRICE SR VP, PAYMENT & HEALTH 251245 0 62850 0 6624 0 26645 0 5557 0 352921 0 0 0 STEVEN BROTMAN SR VP, PAYMENT & HEALTH 304589 0 43450 0 1242 0 29301 0 14211 0 392793 0 0 0 PART I, LINE 1A FIRST CLASS TRAVEL IS AUTHORIZED ONLY IN EXCEPTIONAL CIRCUMSTANCES, SUCH AS WHEN IT IS NECESSARY TO TAKE A SPECIFIC FLIGHT WHERE BUSINESS OR COACH CLASS IS NOT AVAILABLE, AND MUST FIRST HAVE PRIOR WRITTEN APPROVAL BY DEPARTMENT HEADS AND ADVAMED'S PRESIDENT. OTHER EXPENSES INCURRED BY THE TRAVELER FOR TRAVEL OUTSIDE THE DEFINITION OF A BUSINESS TRIP, INCLUDING EXPENSES FOR FAMILY MEMBERS TRAVELING WITH THE EMPLOYEE, ARE ALSO THE RESPONSIBILITY OF THE TRAVELER AND NOT ADVAMED. SUCH EXPENSES ARE KEPT SEPARATE FROM REIMBURSABLE BUSINESS EXPENDITURES. PERSONAL TRAVEL FOR FAMILY MEMBERS/FRIENDS MAY BE BOOKED THROUGH ADVAMED'S TRAVEL AGENCY BUT ARE IDENTIFIED SEPARATELY AND BILLED DIRECTLY TO THE EMPLOYEE. DUE TO THE FREQUENT TRAVEL SCHEDULE AND DEMANDS ON TIME REQUIRED BY THE POSITION, THE PRESIDENT OF ADVAMED MAY TRAVEL BUSINESS CLASS ON ALL INTERNATIONAL FLIGHTS AND FOR TRAVEL OVER 4 HOURS, WHERE SUCH SEATING IS AVAILABLE. SPOUSE'S TRAVEL WILL BE REIMBURSED ONLY WHERE SPOUSE'S ATTENDANCE IS REQUIRED FOR BUSINESS PURPOSES. TRAVEL IS NOT INCLUDED IN TAXABLE INCOME. ADVAMED'S CEO RECEIVED SOCIAL CLUB DUES IN THE AMOUNT OF $6,180 DURING 2013. FORM 990, PART VI, SECTION A, LINE 2 BASED ON A RESPONSE TO A SURVEY DISTRIBUTED TO EACH MEMBER OF ADVAMED, 2 MEMBERS - CAROLL NEUBAUER AND JOE WOODY - INDICATED BUSINESS RELATIONSHIPS WITH OTHER MEMBERS OF THE BOARD. MAURICE FERRE & KEVIN LOBO ALSO HAVE A BUSINESS RELATIONSHIP. FORM 990, PART VI, SECTION A, LINE 6 THE ASSOCIATION HAS TWO CLASSES OF MEMBERSHIPS - ACTIVE AND ASSOCIATE. ANY FIRM OR CORPORATION WHICH, THROUGH ITSELF OR THROUGH ANY OF ITS SUBSIDIARIES OR DIVISIONS, IS SIGNIFICANTLY ENGAGED IN THE MANUFACTURE OF AND/OR THE RESEARCH WITH THE INTENT TO MANUFACTURE MEDICAL DEVICES, DIAGNOSTIC PRODUCTS AND/OR HEALTH CARE INFORMATION SYSTEMS WITHIN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, SHALL BE ELIGIBLE FOR ACTIVE MEMBERSHIP. ANY COMPANY OR ORGANIZATION MAY BE ELIGIBLE AS AN ASSOCIATE MEMBER, IN ACCORDANCE WITH SUCH RULES AND REGULATIONS AS THE BOARD OF DIRECTORS OF THE ASSOCIATION MAY ADOPT ESTABLISHING A CLASS OR CLASSES OF ASSOCIATE MEMBERS AND DETERMINING ELIGIBILITY FOR MEMBERSHIP IN SUCH CLASS OR CLASSES. ASSOCIATE MEMBERS MAY PARTICIPATE IN SUCH AFFAIRS OF THE ASSOCIATION AS MAY BE DETERMINED BY THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 7A EACH ACTIVE MEMBER IN GOOD STANDING SHALL BE ENTITLED TO ONE VOTE ON ANY QUESTION COMING BEFORE THE GENERAL MEMBERSHIP, INCLUDING THE ELECTION OF THE BOARD OF DIRECTORS ANNUALLY. THE BOARD NOMINATING AND GOVERNANCE COMMITTEE PRESENTS A PROPOSED SLATE OF DIRECTORS ANNUALLY TO THE MEMBERSHIP FOR VOTE. EACH ACTIVE MEMBER SHALL, IN WRITING, DESIGNATE ITS OFFICIAL REPRESENTATIVE TO VOTE AND REPRESENT THAT MEMBER IN ALL OF THE AFFAIRS OF THE ASSOCIATION, INCLUDING THE HOLDING OF OFFICE. FORM 990, PART VI, SECTION A, LINE 7B EACH ACTIVE MEMBER IN GOOD STANDING SHALL BE ENTITLED TO ONE VOTE ON ANY QUESTION COMING BEFORE THE GENERAL MEMBERSHIP. EACH ACTIVE MEMBER SHALL, IN WRITING, DESIGNATE ITS OFFICIAL REPRESENTATIVE TO VOTE AND REPRESENT THAT MEMBER IN ALL OF THE AFFAIRS OF THE ASSOCIATION, INCLUDING THE HOLDING OF OFFICE. SUCH OFFICIAL REPRESENTATIVE SHALL BE THE CHIEF EXECUTIVE OFFICER OR CHIEF OPERATING OFFICER OF THE MEMBER OR SUCH OTHER SENIOR OPERATING OFFICER AS THE CHIEF EXECUTIVE OFFICER MAY DESIGNATE. FORM 990, PART VI, SECTION B, LINE 11 AT ITS MEETING IN DECEMBER 2008, THE BOARD OF DIRECTORS RESOLVED TO DELEGATE ITS AUTHORITY FOR THE REVIEW AND APPROVAL OF THE FORM 990 TO THE BOARD COMMITTEE ON FINANCE, AUDIT AND COMPENSATION (FAC). THE FAC REVIEWS THE 990 FILING BEFORE IT IS MADE WITH THE IRS. THE DRAFT OF THE FORM 990 IS MADE AVAILABLE FOR REVIEW BY ALL BOARD MEMBERS ON THE BOARD OF DIRECTORS SECTION OF ADVAMED'S WEBSITE PRIOR TO FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C ADVAMED HAS IN PLACE A CONFLICT OF INTEREST POLICY THAT IS MONITORED REGULARLY. EXCERPTS FROM THE POLICY RELATED TO THIS QUESTION ARE SHOWN BELOW: THE CONFLICT OF INTEREST POLICY OF ADVAMED: (1) DEFINES CONFLICTS OF INTEREST; (2) IDENTIFIES CLASSES OF INDIVIDUALS WITHIN THE ASSOCIATION COVERED BY THIS POLICY; (3) FACILITATES DISCLOSURE OF INFORMATION THAT MAY HELP IDENTIFY CONFLICTS OF INTEREST; AND (4) SPECIFIES PROCEDURES TO BE FOLLOWED IN MANAGING CONFLICTS OF INTEREST. 1. A CONFLICT OF INTEREST ARISES WHEN A PERSON IN A POSITION OF AUTHORITY OVER THE ASSOCIATION MAY BENEFIT FINANCIALLY FROM A DECISION HE OR SHE COULD MAKE IN THAT CAPACITY, INCLUDING INDIRECT BENEFITS SUCH AS TO FAMILY MEMBERS OR BUSINESSES WITH WHICH THE PERSON IS CLOSELY ASSOCIATED. ADVAMED'S POLICY IS FOCUSED UPON MATERIAL FINANCIAL INTEREST OF, OR BENEFIT TO, SUCH PERSONS. 2. PERSONS COVERED BY THIS POLICY ARE THE ASSOCIATION'S STAFF OFFICERS, DIRECTORS, CHIEF EXECUTIVE OFFICER, AND CHIEF ADMINISTRATIVE OFFICER. 3. PERSONS COVERED BY THIS POLICY ANNUALLY DISCLOSE TO THE GENERAL COUNSEL ON A FORM PROVIDED BY THE ASSOCIATION THEIR INTERESTS THAT COULD GIVE RISE TO CONFLICTS OF INTEREST, SUCH AS A LIST OF FAMILY MEMBERS, SUBSTANTIAL BUSINESS OR INVESTMENT HOLDINGS, AND OTHER TRANSACTIONS OR AFFILIATIONS WITH BUSINESSES AND OTHER ORGANIZATIONS OR THOSE OF FAMILY MEMBERS. 4. FOR EACH INTEREST DISCLOSED TO THE GENERAL COUNSEL, THE GENERAL COUNSEL WILL DETERMINE WHETHER TO: (A) TAKE NO ACTION; (B) ASSURE FULL DISCLOSURE TO THE BOARD OF DIRECTORS AND OTHER INDIVIDUALS COVERED BY THIS POLICY; (C) ASK THE PERSON TO RECUSE FROM PARTICIPATION IN RELATED DISCUSSIONS OR DECISIONS WITHIN THE ASSOCIATION; OR (D) ASK THE PERSON TO RESIGN FROM HIS OR HER POSITION IN THE ASSOCIATION OR, IF THE PERSON REFUSES TO RESIGN, BECOME SUBJECT TO POSSIBLE REMOVAL IN ACCORDANCE WITH THE ASSOCIATION'S REMOVAL PROCEDURES. THE ASSOCIATION'S CHIEF ADMINISTRATIVE OFFICER AND VICE PRESIDENT OF FINANCE WILL MONITOR PROPOSED OR ONGOING TRANSACTIONS FOR CONFLICTS OF INTEREST AND DISCLOSE THEM TO THE CHAIRMAN OF THE BOARD OF DIRECTORS IN ORDER TO DEAL WITH POTENTIAL OR ACTUAL CONFLICTS, WHETHER DISCOVERED BEFORE OR AFTER THE TRANSACTION HAS OCCURRED. INTERESTS IN MEMBER COMPANIES: AT TIMES, ADVAMED STAFF AND/OR DIRECTORS MAY BE AWARE OF THE SIGNIFICANT AMOUNT OF INTEREST GENERATED IN CONNECTION WITH NEW PRODUCT DEVELOPMENT, SALES AND PROFITS, PRODUCT REGULATORY STATUS, AND ACQUISITIONS IN THE HEALTH CARE TECHNOLOGY INDUSTRY. THUS, ANYONE IN POSSESSION OF MATERIAL INFORMATION NOT GENERALLY AVAILABLE TO THE INVESTING PUBLIC MUST, IN ORDER TO COMPLY WITH THIS POLICY, EITHER DISCLOSE THAT KNOWLEDGE OR REFRAIN FROM TRADING IN THE STOCK. IN ADDITION, THE PURCHASE OF STOCK IN MEMBER COMPANIES CAN LEAD TO THE APPEARANCE THAT A MEMBER OF THE STAFF AND/OR BOARD OF DIRECTORS IS FAVORING THE INTERESTS OF THAT COMPANY BECAUSE OF SUCH FINANCIAL INTEREST. EVEN IF THERE IS NO ACTUAL CONFLICT OF INTEREST, THE APPEARANCE OF IMPROPRIETY MUST BE AVOIDED. NO EMPLOYEE OF THE ASSOCIATION OR MEMBER OF ITS BOARD OF DIRECTORS, EITHER IN HIS OR HER OWN NAME, OR IN THE NAME OF HIS OR HER SPOUSE OR CHILDREN, MAY PURCHASE STOCK IN ANY MEMBER COMPANY WITHOUT ADVISING THE ASSOCIATION PRESIDENT OF SUCH OWNERSHIP OR CONTEMPLATED OWNERSHIP. IN 2010, ADVAMED REQUIRED EMPLOYEES AND DIRECTORS TO SUBMIT AN ANNUAL FINANCIAL DISCLOSURE STATEMENT TO THE GENERAL COUNSEL REGARDING HOLDINGS IN MEMBER COMPANIES. AFTER REVIEW OF THE COMPLETED FORMS BY THE GENERAL COUNSEL, POTENTIAL CONFLICTS ARE REPORTED TO THE PRESIDENT, WHO REPORTS ANY SUCH DISCLOSURES TO THE CHAIRMAN OF THE BOARD OF DIRECTORS. INTERESTS IN ENTITIES DOING BUSINESS WITH ADVAMED: IN THE COURSE OF ITS DAY-TO-DAY OPERATIONS, ADVAMED CONTRACTS WITH NUMEROUS FIRMS THAT PROVIDE GOODS AND SERVICES. IT IS IMPORTANT THAT THESE FIRMS ARE CHOSEN FOR BUSINESS PURPOSES AND NOT BECAUSE THEY ARE INAPPROPRIATELY FAVORED BY ADVAMED EMPLOYEES OR DIRECTORS WHO MAY HAVE A FINANCIAL INTEREST IN PARTICULAR TRANSACTIONS. ACCORDINGLY, ADVAMED EMPLOYEES AND DIRECTORS MUST DISCLOSE, ON AN ONGOING BASIS, ANY FINANCIAL INTEREST IN A COMPANY WITH WHICH ADVAMED CONTRACTS, OR IS CONSIDERING. FORM 990, PART VI, SECTION B, LINE 15 THE PROCESS INCLUDES ALL OF THESE ELEMENTS: (1) REVIEW AND APPROVAL BY THE BOARD COMMITTEE ON FINANCE, AUDIT AND COMPENSATION OF THE ASSOCIATION; (2) USE OF DATA AS TO COMPARABLE COMPENSATION; AND (3) CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING. 1. REVIEW AND APPROVAL. THE COMPENSATION OF THE PERSON IS REVIEWED AND APPROVED BY THE BOARD COMMITTEE ON FINANCE, AUDIT AND COMPENSATION OF THE ASSOCIATION, PROVIDED THAT PERSONS WITH CONFLICTS OF INTEREST WITH RESPECT TO THE COMPENSATION ARRANGEMENT AT ISSUE ARE NOT INVOLVED IN THIS REVIEW AND APPROVAL. 2. USE OF DATA AS TO COMPARABLE COMPENSATION. THE COMPENSATION OF THE PERSON IS REVIEWED AND APPROVED USING DATA AS TO COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS. 3. CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING. THERE IS CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING WITH RESPECT TO THE DELIBERATIONS AND DECISIONS REGARDING THE COMPENSATION ARRANGEMENT. FORM 990, PART VI, SECTION C, LINE 19 FINANCIAL STATEMENTS, CONFLICT OF INTEREST POLICY AND GOVERNING DOCUMENTS ARE AVAILABLE UPON REQUEST FOR THE SAME PERIOD OF DISCLOSURE AS SET FORTH IN SECTION 6104(D). FORM 990, PART VI, LINE 16A THE ASSOCIATION FORMED A LIMITED LIABILITY COMPANY CALLED MEDTECH CONFERENCE PARTNERS, LLC WITH LIFE SCIENCES CONFERENCE GROUP LLC (LSCG) TO OWN AND OPERATE THE ANNUAL CONFERENCE. FORM 990, PART IX, LINE 11G CONSULTING 4,174,627. OTHER PROFESSIONAL FEES 1,070,747. FORM 990, PART XII, LINE 2C THE PROCESS FOR OVERSEEING THE AUDIT OF THE FINANCIAL STATEMENTS AND SELECTION OF AN INDEPENDENT ACCOUNTANT THAT AUDITED THE FINANCIAL STATEMENTS HAS BEEN CONSISTENT WITH PRIOR YEARS. INSTITUTE FOR HEALTH TECHNOLOGY STUDIES 1319 F STREET NW STE 900 WASHINGTON DC 20004 522281033 PROVIDE SUPPORT FOR MEDICAL DEVICE RESEARCH DC 501(C)(3) LINE 11A, I ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 1 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION POLITICAL ACTION COMMITTEE 701 PENNSYLVANIA AVENUE NW STE 800 WASHINGTON DC 20004 POLITICAL ACTION COMMITTEE DC 527 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 1 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION CA PAC 701 PENNSYLVANIA AVENUE NW STE 800 WASHINGTON DC 20004 455309081 POLITICAL ACTION COMMITTEE DC 527 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 1 MEDTECH CONFERENCE PARTNERS LLC 701 PENNSYLVANIA AVENUE NW STE 800 WASHINGTON DC 20004 364725626 TRADE SHOW DC ADVANCED MEDICAL TECHNOLOGY ASSOCIATION RELATED 478257 83379 1 1 0.75000 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 1 INSTITUTE FOR HEALTH TECHNOLOGY STUDIES Q 154853 CASH MEDTECH CONFERENCE PARTNERS LLC S 478257 CASH